Assembly Biosciences (ASMB) Amortization - Intangibles (2010 - 2011)
Assembly Biosciences (ASMB) recorded quarterly Amortization - Intangibles of $253302.0 in Q3 2011, up 933.38% quarter-over-quarter from $24512.0 in Q2 2011, and down 56.34% on a YoY basis from $580217.0 in Q3 2010.
Assembly Biosciences (ASMB) Amortization - Intangibles (2010 - 2011) Analysis & Trends
Assembly Biosciences' Amortization - Intangibles history runs 2 years deep, the most recent figure standing at $253302.0 for Q3 2011.
- In Q3 2011, Amortization - Intangibles fell 56.34% year-over-year to $253302.0; the TTM figure through Jun 2012 stood at $253302.0 (down 59.74% YoY), while the FY2011 annual figure was $302327.0, down 87.83% from the prior year.
- Amortization - Intangibles was $253302.0 for Q3 2011 at Assembly Biosciences, up from $24512.0 in the prior quarter.
- In the past five years, Amortization - Intangibles ranged from a high of $784787.0 in Q2 2010 to a low of $24512.0 in Q2 2011.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Assembly Biosciences | 418.96 Mn | 192.36 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2011 | 253,302.00 |
| Jun 30, 2011 | 24,512.00 |
| Mar 31, 2011 | 24,513.00 |
| Sep 30, 2010 | 580,217.00 |
| Jun 30, 2010 | 784,787.00 |